Michael Kishbauch

2010

In 2010, Michael Kishbauch earned a total compensation of $1.9M as Director, President and Chief Executive Officer at Achillion Pharmaceuticals, a 106% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$240,000
Option Awards$1,227,270
Salary$394,800
Other$7,673
Total$1,869,743

Kishbauch received $1.2M in option awards, accounting for 66% of the total pay in 2010.

Kishbauch also received $240K in non-equity incentive plan, $394.8K in salary and $7.7K in other compensation.

Rankings

In 2010, Michael Kishbauch's compensation ranked 3,276th out of 10,439 executives tracked by ExecPay. In other words, Kishbauch earned more than 68.6% of executives.

ClassificationRankingPercentile
All
3,276
out of 10,439
69th
Division
Manufacturing
1,147
out of 3,838
70th
Major group
Chemicals And Allied Products
224
out of 921
76th
Industry group
Drugs
122
out of 680
82nd
Industry
Pharmaceutical Preparations
91
out of 481
81st
Source: SEC filing on April 12, 2013.

Kishbauch's colleagues

We found five more compensation records of executives who worked with Michael Kishbauch at Achillion Pharmaceuticals in 2010.

2010

Milind Deshpande

Achillion Pharmaceuticals

Chief Scientific Officer

2010

Joseph Truitt

Achillion Pharmaceuticals

Senior Vice President and Chief Commercial Officer

2010

Gautam Shah

Achillion Pharmaceuticals

Executive Vice President and Chief Compliance Officer

2010

Elizabeth Olek

Achillion Pharmaceuticals

Chief Medical Officer

2010

Mary Fenton

Achillion Pharmaceuticals

Chief Financial Officer

In-depth

You may also like